Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Brase

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Molecular Cancer|November 30, 2010
Serum microRNAs as non-invasive biomarkers for cancerJan C Brase, Daniela Wuttig, Ruprecht Kuner, et al.
Methods (San Diego, Calif.)|June 2, 2012
microRNA biomarkers in body fluids of prostate cancer patientsRuprecht Kuner, Jan C Brase, Holger Sültmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Antibody-mediated signal amplification for reverse phase protein array-based protein quantificationJan C Brase, Heiko Mannsperger, Holger Sültmann, et al.
Microarrays (Basel, Switzerland)|September 9, 2016
From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer PrognosisJan C Brase, Ralf Kronenwett, Christoph Petry, et al.
Pharmacogenomics|July 4, 2008
Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?Mathias Gehrmann, Markus Schmidt, Jan C Brase, et al.
Bioinformatics (Oxford, England)|July 2, 2010
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patientsMarc Johannes, Jan C Brase, Holger Fröhlich, et al.
International Journal of Cancer|May 18, 2010
Circulating miRNAs are correlated with tumor progression in prostate cancerJan C Brase, Marc Johannes, Thorsten Schlomm, et al.
BMC Bioinformatics|December 23, 2011
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancerStephan Gade, Christine Porzelius, Maria Fälth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Gynecologic Oncology|May 24, 2011
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavageAnne-Kathleen Rupp, Christian Rupp, Sascha Keller, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Molecular Cancer|November 30, 2010
Serum microRNAs as non-invasive biomarkers for cancerJan C Brase, Daniela Wuttig, Ruprecht Kuner, et al.
Methods (San Diego, Calif.)|June 2, 2012
microRNA biomarkers in body fluids of prostate cancer patientsRuprecht Kuner, Jan C Brase, Holger Sültmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Antibody-mediated signal amplification for reverse phase protein array-based protein quantificationJan C Brase, Heiko Mannsperger, Holger Sültmann, et al.
Microarrays (Basel, Switzerland)|September 9, 2016
From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer PrognosisJan C Brase, Ralf Kronenwett, Christoph Petry, et al.
Pharmacogenomics|July 4, 2008
Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?Mathias Gehrmann, Markus Schmidt, Jan C Brase, et al.
Bioinformatics (Oxford, England)|July 2, 2010
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patientsMarc Johannes, Jan C Brase, Holger Fröhlich, et al.
International Journal of Cancer|May 18, 2010
Circulating miRNAs are correlated with tumor progression in prostate cancerJan C Brase, Marc Johannes, Thorsten Schlomm, et al.
BMC Bioinformatics|December 23, 2011
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancerStephan Gade, Christine Porzelius, Maria Fälth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Gynecologic Oncology|May 24, 2011
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavageAnne-Kathleen Rupp, Christian Rupp, Sascha Keller, et al.
Pageof 5